Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Activated protein C versus placebo for inflammatory or infectious ALI/ARDS (INFALI)
NL-OMON21017Recruiting
- Sponsor
- VU University Medical Center (VUmc), department of Intensive Care
- Start
- Sep 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) comparing Activated protein C with Placebo (2 arms). Primary endpoint: Pulmonary microvascular permeability. Started Sep 2006; status: recruiting.
02
Drugs
drotrecogin alfa
03
Conditions
acute lung injury (ALI)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NL-OMON21017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21017.